Please contact us for more information or to learn if you are eligible to participate.
A study for patients with Type 1 Diabetes Mellitus that compares the safety and efficacy of MYL-1601D with NovoLog®
Principal Investigator | Marcel B. Twahirwa, MD |
Sponsor | Mylan GmbH/Switzerland |
Type of Trial | Interventional |